Does NADROPARIN Cause Off label use? 77 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Off label use have been filed in association with NADROPARIN. This represents 11.4% of all adverse event reports for NADROPARIN.
77
Reports of Off label use with NADROPARIN
11.4%
of all NADROPARIN reports
17
Deaths
44
Hospitalizations
How Dangerous Is Off label use From NADROPARIN?
Of the 77 reports, 17 (22.1%) resulted in death, 44 (57.1%) required hospitalization, and 6 (7.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NADROPARIN. However, 77 reports have been filed with the FAERS database.
What Other Side Effects Does NADROPARIN Cause?
Foetal exposure during pregnancy (81)
Premature baby (73)
Maternal exposure during pregnancy (72)
Drug ineffective (54)
Sepsis (46)
Dyspnoea (44)
Fall (43)
Exposure during pregnancy (42)
Confusional state (40)
Diarrhoea (34)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which NADROPARIN Alternatives Have Lower Off label use Risk?
NADROPARIN vs NAFARELIN
NADROPARIN vs NAFCILLIN
NADROPARIN vs NAFCILLIN\NAFCILLIN
NADROPARIN vs NAFRONYL
NADROPARIN vs NAFTIFINE